We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Phase 3 Trials of Allergan’s UTI Drug Support FDA’s Priority Review
Phase 3 Trials of Allergan’s UTI Drug Support FDA’s Priority Review
Allergan said Wednesday that results from two Phase 3 studies evaluating Avycaz in hospitalized adults with complicated urinary tract infections, including pyelonephritis, affirm the drug’s safety and efficacy.